Northwestern is going to work on finding a cure for a common type of asthma.
Chronic rhinosinusitis, commonly known as CRS, is one of the most common forms of asthma in the United States. Experts from the Centers for Disease Control and Prevention (CDC) estimate that nearly 30 million Americans suffer from this chronic breathing affliction.
Patients who have CRS have pain and congestion in their sinuses that are caused by an inflammation from an infection or other outside irritants to their system. The disease is one that is long-lasting, with people suffering from this pain for more than 12 weeks to several years. Experts estimate that $6 billion in healthcare costs are spent on the treatment of this illness. Now, researchers hope to get to the bottom of what causes this problem.
Chicago’s Northwestern University has received an $8.4 million dollar grant from the National Institute of Allergy and Infectious Diseases, which is a part of the National Institutes of Health. The money will be used for the study of CRS while also working on the development of possible treatment methods. The grant is being given to Northwestern’s newly-established Chronic Rhinosinusitis Integrative Studies Program, which is made up of research groups from Northwestern Medicine, Geisinger Health System and the University of Chicago.
“Treatments for chronic rhinosinusitis have remained largely unchanged for decades and there is a great need for more research,” chief researcher Dr. Robert P. Schleimer said in a public statement. He went on to talk about how the group hopes to cut down on the issues faced by those who suffer from CRS.
If you are somebody who has any kind of difficulty breathing, invest in a home air purifier from US Air Purifiers Direct 2U. Our high-quality products will help keep the air in your home free from irritants, allowing you to breathe easier.